Related references
Note: Only part of the references are listed.Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
V. L. Yip et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
M. A. Martin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: Incidence, features, risk factors and relation to HLA-B alleles
Na He et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Usefulness of F-18 FDG PET/CT in the Evaluation of Neck Swelling in Polymorphic Posttransplant Lymphoproliferative Disorder After Renal Transplantation
Sung Hoon Kim et al.
CLINICAL NUCLEAR MEDICINE (2011)
Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
M. Pirmohamed et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions
Chaichon Locharernkul et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Pei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PharmGKB summary: carbamazepine pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population
Fa-yun Hu et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Phenytoin-induced Stevens-Johnson syndrome with negative HLA-B*1502 allele in mainland China: Two cases
Fa-Yun Hu et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India
Umapathy Shankarkumar et al.
EPILEPSIA (2009)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype
Y-C Chen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
OXCARBAZEPINE-INDUCED STEVENS-JOHNSON SYNDROME: A CASE REPORT
Lung-Chang Lin et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2009)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
Ana Alfirevic et al.
PHARMACOGENOMICS (2006)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
AM Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
A Nassif et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
DJ Naisbitt et al.
MOLECULAR PHARMACOLOGY (2003)
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
A Nassif et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Share Paper
